Primary leiomyosarcoma of the vagina. A case report and literature review. 2000

G. Ciaravino, and D. S. Kapp, and A. M. Vela, and R. S. Fulton, and B. L. Lum, and N. N. H. Teng, and J. A. Roberts
Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Stanford University School of Medicine, and Departments of Radiation Oncology and Pathology, Clinical Cancer Center, Stanford University Hospital, Stanford, California.

Primary vaginal leiomyosarcoma is a rare tumor. We report a unique case of a 27-year-old woman with stage I, high-grade primary leiomyosarcoma of the vagina treated with surgical resection and adjuvant radiation therapy. She returned within 6 months with an abdominal-pelvic recurrence and lung metastases. The patient died of disease 9 months after diagnosis. A comprehensive review of primary vaginal leiomyosarcoma was performed and factors affecting survival were analyzed. A Medline search of the English-language literature revealed 66 previously reported cases. Forty-eight of these had follow-up data. Survival probabilities were calculated using the Kaplan-Meier method, and the effects of age, stage, grade, tumor location, and treatment modality were analyzed. Stage III and IV data were combined. The overall 5-year survival rate was 43%. Patients more than 50 years of age had a 5-year survival rate of 26% compared with 51% for those less than 40 years. Five-year survival for stage I and II tumors was 55% and 44%, respectively. Patients with stage III/IV disease had 25% survival at 18 months. No patient treated primarily with chemotherapy or radiation therapy survived beyond 36 months. In contrast, patients treated primarily with surgery had a 5-year survival rate of 57%. Only stage remained an independent predictor of survival on Cox regression analysis. We continue to recommend surgical resection as primary treatment. Exenteration may be an option for select patients, but ultimately management should continue on a case-by-case basis.

UI MeSH Term Description Entries

Related Publications

G. Ciaravino, and D. S. Kapp, and A. M. Vela, and R. S. Fulton, and B. L. Lum, and N. N. H. Teng, and J. A. Roberts
January 2007, La Tunisie medicale,
G. Ciaravino, and D. S. Kapp, and A. M. Vela, and R. S. Fulton, and B. L. Lum, and N. N. H. Teng, and J. A. Roberts
January 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
G. Ciaravino, and D. S. Kapp, and A. M. Vela, and R. S. Fulton, and B. L. Lum, and N. N. H. Teng, and J. A. Roberts
January 2015, Akusherstvo i ginekologiia,
G. Ciaravino, and D. S. Kapp, and A. M. Vela, and R. S. Fulton, and B. L. Lum, and N. N. H. Teng, and J. A. Roberts
December 2008, Journal of gynecologic oncology,
G. Ciaravino, and D. S. Kapp, and A. M. Vela, and R. S. Fulton, and B. L. Lum, and N. N. H. Teng, and J. A. Roberts
August 1958, Obstetrics and gynecology,
G. Ciaravino, and D. S. Kapp, and A. M. Vela, and R. S. Fulton, and B. L. Lum, and N. N. H. Teng, and J. A. Roberts
January 2008, Clinical medicine. Oncology,
G. Ciaravino, and D. S. Kapp, and A. M. Vela, and R. S. Fulton, and B. L. Lum, and N. N. H. Teng, and J. A. Roberts
September 2022, World journal of hepatology,
G. Ciaravino, and D. S. Kapp, and A. M. Vela, and R. S. Fulton, and B. L. Lum, and N. N. H. Teng, and J. A. Roberts
January 2020, Case reports in urology,
G. Ciaravino, and D. S. Kapp, and A. M. Vela, and R. S. Fulton, and B. L. Lum, and N. N. H. Teng, and J. A. Roberts
June 2016, Oncology letters,
G. Ciaravino, and D. S. Kapp, and A. M. Vela, and R. S. Fulton, and B. L. Lum, and N. N. H. Teng, and J. A. Roberts
October 2011, World journal of gastrointestinal oncology,
Copied contents to your clipboard!